Physician profile
John Taylor
NPI 1033606181
$3,110.68
in general payments reported to CMS, 2019-2025
9 companies · $517 in 2025
The $517 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.00 · 2022: $52.31 · 2023: $757 · 2024: $1,763 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,703 · Food and Beverage: $811 · Education: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,703.02 |
| Food and Beverage | $811.36 |
| Education | $521.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,745.87 | 2024 | Carto 3 |
| Biotronik INC. | $818.98 | 2023-2025 | Acticor 7 Vr-T Dx, Plexa Promri |
| Biosense Webster, INC. | $315.44 | 2024-2025 | Carto 3 |
| Medtronic, INC. | $70.71 | 2021-2025 | Selectsecure |
| E.R. Squibb & Sons, L.L.C. | $65.86 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.33 | 2023 | Jardiance |
| Daiichi Sankyo INC. | $24.98 | 2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $19.10 | 2022 | |
| Amgen INC. | $15.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.